The Catalyst

Most Recent Posts


Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting throughout the year to share thoughts on the program and its importance.


In doing some preliminary research, I find that my original premise for a new state policy paper I'm writing is spot-on accurate: greater awareness, prevention and treatment of chronic diseases are the best way to improve health and lower health care costs, not arbitrary cuts and restrict

12.06.12 | By Mark Grayson

According to a recent survey by the U.S. Food and Drug Administration, nearly one in four adult Internet consumers has purchased prescription medicine online.


Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting through the rest of the year.

Grace Boatright, legislative director of the National Grange, shared her views on Part D and the positive impact it has had on Grange members.

12.05.12 | By Stephanie Fischer

Not surprisingly, PhRMA was not alone in objecting to the one-sided article on clinical trials which was recently featured on the front page of the


[caption id="attachment_5026" align="alignleft" width="150" caption="Photo used under Creative Commons from NHSE"][/caption]

12.04.12 | By Scott LaGanga

Today we've got a guest post from Darrell Roberts, Executive Director of Helmets to Hardhats.


Today we've got a guest post from Anne Whitaker, President, North America Pharmaceuticals of Sanofi.

12.04.12 | By Jay Taylor, By Jay Taylor

Now that the election season is behind us, the U.S. trade agenda appears set to heat up. Last week, during a trip to Asia President Obama stressed the importance of the Trans-Pacific Partnership (TPP) - not only for U.S. trade policy but for greater U.S. geopolitical purposes.


In November, the President's Council of Advisors on Science and Technology (PCAST) issued a report focusing on what they view as the necessary steps to

11.30.12 | By Scott LaGanga

Earlier this week, the Partnership for Safe Medicines (PSM) officially launched PSM China, the latest international public-private collaboration to help address the growing threat posed by counterfeit drugs. In addition to PhRMA Chairman and Eli Lilly President and CEO Dr.


Today we've got a guest post from Thomas F. Goss, Senior Vice President of Boston Healthcare Associates, Inc.

11.30.12 | By Rick Smith

Yesterday the Congressional Budget Office (CBO) released a report describing revised methodology for estimating the fi


Last week we noticed two new studies that demonstrate the health benefits of communication about innovative medicines to patients. These studies add to the evidence that direct-to-consumer (DTC) advertisements help patients discuss new treatment options with their doctors and nurses.

11.30.12 | By Christian Clymer

In honor of National Diabetes Awareness Month, we want to share with you the story of a recently diagnosed Type II Diabetes patient and her experience with a prescription assistance program: